INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
INJECTION
INJECTION
Antonio Scatena
Gateway Analytical
BEYOND PROBABILITY: CHOOSING DETERMINISTIC METHODS FOR RELIABLE CONTAINER CLOSURE INTEGRITY TESTING
Antonio Scatena answers some of the most common questions regarding the container closure integrity testing methods used to detect leaks and defects – and discusses how the industry can meet the updated expectations set by regulatory bodies.
INJECTION
Dr Farid Seddighi
Gerresheimer
COMPREHENSIVE TESTING PROVES DESIGN CONCEPT OF NOVEL AUTOINJECTOR PLATFORM
Farid Seddighi, Sigrid Saaler-Reinhardt and Daniel Primavessy discuss the critical importance of testing at an early stage of medical device development, presenting an overview of the results that confirm the technical performance and usability of the novel Gx Inbeneo
®
autoinjector.
EXPERT VIEW
Kyle Toole
DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS
Kyle Toole, Blair Hutton and James McLusky discuss the value that mathematical modelling can provide in the early stages of injectable drug delivery device development, especially when coupled with appropriate empirical testing in a laboratory setting.
SKIN
Dr Nicky Bertollo
Pharma Latch
IT’S TIME TO CONSIDER INTRADERMAL DELIVERY
Nicky Bertollo, Adam Rock and Saidhbh O’Callaghan discuss the progress Pharma Latch’s intradermal drug delivery platform is making towards realising the potential the intradermal route offers to drug developers, especially for vaccines.
SUSTAINABILITY
Philipp Ludihuser
SCHOTT Pharma
PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY
Philipp Ludihuser and Arne Kloke highlight how SCHOTT Pharma’s collaboration with customers and partners in the pharmaceutical industry reduces the carbon emissions from the production of vials, cartridges, ampoules and syringes, as well as introducing circular solutions to increase resource efficiency.
SUSTAINABILITY
Jessica Buday
Corning
PRIORITISING SUSTAINABILITY IN PHARMA
Jessica Buday discusses how, in partnership with West Pharmaceutical Services, Corning’s Viridian glass vials are able to simultaneously improve the sustainability and efficiency of pharmaceutical fill-finish lines compared with traditional ISO glass vials, due to their reduced glass volume and proprietary external polymeric coating.
SUSTAINABILITY
John Merhige
Credence MedSystems
OPPORTUNITY THROUGH INNOVATION – ENVIRONMENTAL AND SOCIAL SUSTAINABILITY IN INJECTION DEVICES
John Merhige and Dan Thayer discuss how the successful implementation of ESG principles in the pharmaceutical sector requires innovation that allows sustainability to be seen as an opportunity rather than a burden. Furthermore, the authors present the case that improving on the social aspect of ESG is just as important as improving on the environmental side.
SUSTAINABILITY
David Pircher
Baumann Medical
CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY
David Pircher provides insights from a sustainability journey, showcasing what suppliers can contribute and how innovation and partnership support a common vision. The article outlines where the industry stands and why sustainability is a top priority, with concrete examples.
WEARABLES
Dr Leonard Chu
Altek Medical
ENABLING LARGE-VOLUME SUBCUTANEOUS INJECTION WITH A SMART WEARABLE INJECTION PLATFORM
Leonard Chu presents the Altek Biotechnology's Alby injection platform and highlights its versatility as a delivery platform for large-volume subcutaneous injections.
WEARABLES
Dr Greg Moakes
LTS
TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING
Greg Moakes and Tzach Sadi the process and benefits of automating the production process for its on-body injector device, Sorrel™.
WEARABLES
Cecile Gross
Nemera
SYMBIOZE
®
: LARGE-VOLUME ON-BODY INJECTOR PLATFORM FOSTERING PATIENTS’ EXPERIENCE
Cécile Gross and Mark Tunkel discuss the how Nemera's on-body injector platform – Symbioze
®
– has been developed by drawing on a combination of lessons learned from the history of injection devices and the company’s extensive experience developing drug delivery devices for the parenteral route.
WEARABLES
Anna Allegro
Stevanato Group
UNLOCKING OPPORTUNITIES IN ON-BODY DELIVERY SYSTEMS THROUGH A PLATFORM TECHNOLOGY APPROACH
Anna Allegro and Andrea Cuccato discuss how Stevanato’s Vertiva
®
on-body delivery system exemplifies a platform technology approach to device design, with its 3 and 10 mL formats providing the flexibility necessary to accommodate a wide variety of therapies.
WEARABLES
Simon Bürdel
Gerresheimer
THE IMPORTANCE OF USER-CENTRIC DESIGN WHEN DEVELOPING DEVICES FOR HOME USE
Simon Bürdel and Reza Abedian, discuss the importance and value of conducting human factors studies and user consultations above and beyond regulatory requirements when designing user-centric devices for subcutaneous self-injection in at-home settings.
WEARABLES
Jimmy Fan
CC Bio
CCBio’s Quick Dose On-Body Injector
Quick Dose is a reusable on-body injector designed and developed to address the challenges of drug container compatibility and extend the lifecycle. The device aims to provide a more efficient and comfortable drug delivery method for patients and meet evolving market needs.
WEARABLES
Peter Schmidt
ZwickRoell
FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS
Peter Schmidt details the advantages ZwickRoell’s integrated testing systems offer for ensuring precise and accurate testing of on-body drug delivery systems, including the prevention of static charge and the company’s advanced camera-based measurement systems.
WEARABLES
Omar Rahman
Enable Injections
ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY
Omar Rahman, Beth Faiman and Lisa Gorski highlight the importance of a comfortable experience for both patients and healthcare providers when it comes to large-volume subcutaneous drug delivery.
WEARABLES
Dr Andrea Allmendinger
ten23 health
TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS
Andrea Allmendinger, Michael Adler, Carole Delauney and Hanns-Christian Mahler provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.
EARLY INSIGHT
Dr Chaoyoung Lee
TxSphere
DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE
Chaoyoung Lee and Mike Stout introduce the Horizon wearable micro-pump platform, a cutting-edge advancement in the drug delivery device market that marks a significant contribution to wearable drug-device design.
EXPERT VIEW
Dave Beckstoffer
THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS
Dave Beckstoffer considers how involving customisation from the outset of an on-body injector development project can not only optimise the patient outcome but also streamline the development timescale for device engineers, with a particular focus on the drive system.
INDUSTRIALISATION
Lorenzo Vaccarella
Paragon Medical
FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN
Lorenzo Vaccarella highlights six critical areas to consider early in the drug delivery device development journey. He discusses how strategically investing time during the early stages of the design cycle and throughout development can ultimately save both time and cost down the road when the product is being manufactured and deployed into the market.
INDUSTRIALISATION
Lars Keinicke Hansen
Stevanato Group
DELIVERING INTELLIGENT AUTOINJECTOR ASSEMBLY SOLUTIONS FOR COMPLEX CUSTOMER-SPECIFIC REQUIREMENTS
Lars Keinicke Hansen discusses the potential of technology to enhance the efficiency and productivity of manufacturing processes for both pharmaceutical companies and contract development and manufacturing organisations, as well as the skills and expertise required to maximise the potential gains technology can offer.
INDUSTRIALISATION
Michael Wiglenda
Gerresheimer
FROM IDEA TO MASS PRODUCTION: RAPIDLY AND SAFELY INDUSTRIALISING INNOVATIONS
Michael Wiglenda describes Gerresheimer’s approach to the industrialisation of drug delivery devices, using the production of the company’s Gx Inbeneo
®
cartridge-based autoinjector as an example.
INDUSTRIALISATION
Colby Chen
SHL Medical
AUTOMATING HIGH-MIX, LOW-TO-MEDIUM-VOLUME AUTOINJECTOR ASSEMBLY
Colby Chen and Ian Chang discuss how the introduction of modularity can close the gap in traditional assembly systems to enable fully automated, high-quality autoinjector assembly in support of low- volume/high-mix manufacturing.
INDUSTRIALISATION
Ian Thompson
Ypsomed
YPSOMED’S PLATFORM PRODUCT TRANSFORMATION AND APPROACH TO STRATEGIC PARTNER NETWORKING FOR SELF-INJECTION DEVICES
Ian Thompson describes how Ypsomed has transformed the market for platform-based self-injection devices and extended the concept of platform products beyond the core device by developing working practices with strategic networking partners, helping pharma companies and patients to source safe, reliable and easy-to-use drug-device combination products.
Prev
1
…
7
8
9
10
11
…
44
Next
Top
